Growing community of inventors

Mendon, MA, United States of America

Karen G Bulock

Average Co-Inventor Count = 5.70

ph-index = 6

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 113

Karen G BulockJames Cardia (6 patents)Karen G BulockAnastasia Khvorova (5 patents)Karen G BulockTod M Woolf (5 patents)Karen G BulockJoanne Kamens (5 patents)Karen G BulockWilliam Salomon (5 patents)Karen G BulockDmitry Samarsky (5 patents)Karen G BulockPamela A Pavco (4 patents)Karen G BulockLyn Libertine (4 patents)Karen G BulockMichael Francis Byrne (2 patents)Karen G BulockMichelle Miller (2 patents)Karen G BulockGerard Cauwenbergh (2 patents)Karen G BulockJoke Hedwig Vandesompele (1 patent)Karen G BulockGert Van Peer (1 patent)Karen G BulockKaren G Bulock (8 patents)James CardiaJames Cardia (22 patents)Anastasia KhvorovaAnastasia Khvorova (202 patents)Tod M WoolfTod M Woolf (50 patents)Joanne KamensJoanne Kamens (30 patents)William SalomonWilliam Salomon (28 patents)Dmitry SamarskyDmitry Samarsky (22 patents)Pamela A PavcoPamela A Pavco (13 patents)Lyn LibertineLyn Libertine (8 patents)Michael Francis ByrneMichael Francis Byrne (14 patents)Michelle MillerMichelle Miller (2 patents)Gerard CauwenberghGerard Cauwenbergh (2 patents)Joke Hedwig VandesompeleJoke Hedwig Vandesompele (1 patent)Gert Van PeerGert Van Peer (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Phio Pharmaceuticals Corp. (5 from 22 patents)

2. Rxi Pharmaceuticals Corporation (3 from 16 patents)

3. Biogazelle Nv (1 from 1 patent)


8 patents:

1. 11396654 - Neutral nanotransporters

2. 11279934 - Methods for treating cancer using nucleic acids targeting MDM2 or MYCN

3. 11021707 - Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA

4. 11001845 - Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)

5. 10913948 - RNA interference in dermal and fibrotic indications

6. 10138485 - Neutral nanotransporters

7. 9963702 - RNA interference in dermal and fibrotic indications

8. 9340786 - RNA interference in dermal and fibrotic indications

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/9/2025
Loading…